US & Europe · Independent Updated August 2026
The Banned in Europe Registry
Explainers

The Benzene in Your Dry Shampoo Wasn't Supposed to Be There

A wave of recalls pulled Dove, Suave, Pantene and Proactiv off shelves over a known carcinogen. The honest story isn't that Europe banned an ingredient America allows. It's about what happens after a contaminated batch ships, and who's watching.

By 8 min read Explainers

Every so often a headline lands that reads like a tidy morality play. “Cancer-causing chemical found in your dry shampoo.” Big brands, a scary molecule, a recall. And the reflex, if you spend any time on this site, is to ask the obvious question: is this one of those things Europe already banned?

The honest answer is more interesting than a yes. Benzene is already banned as a cosmetic ingredient. On both sides of the Atlantic. Nobody is putting it in dry shampoo on purpose, and no regulator anywhere allows them to. So the dry shampoo recalls of the last few years aren’t a story about a permitted ingredient. They’re a story about contamination, about quality control in a supply chain, and about what a regulator can actually do once a bad batch is already in your bathroom cabinet. That last part is where Europe and America genuinely diverge, and it’s less obvious than a banned-ingredient list.

Let me walk through what’s actually true.

What benzene is, and why it’s not an ingredient

Benzene is a colorless, sweet-smelling hydrocarbon. It’s one of the most studied human carcinogens we have, tied clearly to leukemia and other blood cancers through decades of occupational data on workers exposed to it in oil refining, rubber, and shoemaking. There’s no serious scientific dispute here. Benzene causes cancer, and there’s no known safe level of long-term exposure.

Here’s the thing to hold onto: benzene does nothing for a cosmetic. It doesn’t clean, it doesn’t scent, it doesn’t hold your hair in place. No formulator writes it into a recipe. When it shows up in a spray can, it’s a stowaway, not a passenger.

So where does it come from? Mostly the propellant. Aerosol dry shampoos push product out of the can using compressed gases like propane, butane, and isobutane. Those are petroleum distillates, refined from crude oil, and benzene is a natural contaminant of petroleum. The propellants are supposed to be purified so no benzene rides along. The word “supposed” is doing a lot of work in that sentence. When purification is sloppy, or a supplier cuts a corner, or a raw material isn’t filtered properly, benzene comes through. The FDA has pointed to the propellant as the source, and Unilever said much the same in its own recall notice, blaming the propellant that sprays the product out of the can.

The recalls, in order

The benzene-in-personal-care saga didn’t start with dry shampoo. It started with an independent lab.

Valisure, an analytical pharmacy and testing lab in Connecticut, began flagging benzene in consumer products in 2021, first in hand sanitizers, then sunscreens, then aerosol sprays. In late 2022 the lab reported finding benzene in 70 percent of the dry shampoos it tested, 103 out of 148 samples, with some batches running many times over the 2 parts-per-million limit the FDA uses for drugs.

The recalls followed the testing. Procter & Gamble moved first, in December 2021, pulling Pantene and Herbal Essences aerosol dry shampoos and conditioners after testing its aerosol portfolio. Then in October 2022 Unilever issued a sweeping voluntary recall of aerosol dry shampoos made before October 2021 across Dove, Nexxus, Suave, TIGI, Rockaholic, Bed Head, and TRESemmé.

And it didn’t stop with hair. In 2024 Valisure turned its attention to acne treatments and found benzene forming in benzoyl peroxide products, sometimes at extraordinary levels when the products were heated, because benzoyl peroxide can degrade into benzene over time and at temperature. The FDA ran its own testing of 95 benzoyl peroxide products, and in March 2025 six of them were voluntarily recalled at the retail level, including a La Roche-Posay product, two Proactiv products, and a couple of store-brand treatments. The vast majority had no detectable benzene, which is worth saying plainly. This isn’t a case of every product being poisoned. It’s a case of quality control failing intermittently, which is its own kind of problem.

So is it “banned in Europe”?

Yes, and that’s exactly why the framing trips people up.

In the EU, benzene sits on Annex II of the Cosmetics Regulation, Regulation (EC) No 1223/2009, the list of substances prohibited in cosmetic products. As of 2025 that list runs to more than 1,700 entries. Benzene is not allowed as an ingredient in a European cosmetic. Full stop.

But here’s the wrinkle that matters for a contaminant. Article 17 of the same regulation deals with traces of prohibited substances. It says the unintended presence of a small amount of a banned substance, coming from impurities, the manufacturing process, or storage, is permitted only if it’s technically unavoidable under good manufacturing practice and the product is still safe for human health. In plain terms: Europe doesn’t pretend a zero is always achievable, but it puts the burden on the manufacturer to prove the trace couldn’t reasonably have been prevented and doesn’t endanger anyone. For a known carcinogen with no safe threshold, “technically unavoidable” is a very hard bar to clear, because we already know it’s possible to refine propellants that don’t carry detectable benzene.

Now compare the American side. The FDA has never set a specific numerical limit for benzene in cosmetics. The often-cited 2 ppm figure comes from drug manufacturing guidance, not cosmetics rules. Benzene isn’t a permitted cosmetic ingredient in the US either, but the framework around impurities has historically been thinner, and enforcement has leaned on the manufacturer noticing a problem and pulling the product itself. Every recall in this story was voluntary.

So the transatlantic gap here isn’t “Europe banned the ingredient and America didn’t.” Both banned the ingredient. The gap is architectural, and it’s about the machinery that runs before and after a product ships.

The real difference is the machinery, not the ingredient list

Europe’s cosmetics system is built to catch problems on the way in. Every product sold in the EU needs a designated Responsible Person, a documented safety assessment, and manufacturing under a recognized good-manufacturing-practice standard, ISO 22716. A prohibited-substance trace has to be justified in the product’s safety file. The philosophy is pre-market: prove it’s clean and safe before it reaches a shelf.

The American system has, for most of its history, been the mirror image. For 84 years, the last major overhaul of US cosmetics law was the Food, Drug, and Cosmetic Act of 1938. The FDA couldn’t even order a cosmetics recall. It could ask, and companies almost always said yes, but the authority to compel wasn’t there.

That’s the piece that just changed. The Modernization of Cosmetics Regulation Act, MoCRA, passed in December 2022, and it’s the biggest shift in US cosmetics regulation since 1938. It requires manufacturers to register their facilities with the FDA, list every product, substantiate safety, report serious adverse events, and, crucially, it gives the FDA explicit authority to mandate a recall when a product is adulterated and poses a serious health risk. By early 2026 the FDA had more than 14,000 registered facilities and nearly a million product listings in the system.

But MoCRA is still half-built. The law told the FDA to propose good-manufacturing-practice rules by the end of 2024 and finalize them by the end of 2025. As of early 2026, no final GMP rule has been issued. The recall authority exists on paper, and the FDA put out draft guidance on how it would use it in December 2025, but the manufacturing-standard backbone that would prevent benzene from getting into a can in the first place isn’t finalized. America is moving toward the European model. It just hasn’t arrived.

What this means when you’re standing in the aisle

A few honest takeaways, in both directions.

Don’t panic about a can you used two years ago. Benzene’s cancer risk is a story about long-term, repeated exposure, the kind refinery workers faced over careers, not a single spritz. The recalls were a precaution against a pattern, not evidence that any one person got sick.

Do take the aerosol format seriously as the variable. This was overwhelmingly a propellant problem, so pump sprays, powders, and non-aerosol formats sidestep the main contamination route entirely. If you want to reduce the odds to near zero, the delivery method matters more than the brand.

And keep the frame straight. This isn’t a case where Europe was smarter about what to allow. Both systems ban benzene. Europe was simply built to catch the failure earlier, through mandatory manufacturing standards and a safety file that has to account for impurities before the product ships. America is finally building the same machinery through MoCRA, and until the manufacturing rules are final, the US model still leans on companies and independent labs like Valisure to spot the problem after the fact.

The uncomfortable truth underneath all of this is that a contaminant is harder to legislate than an ingredient. You can ban a molecule with a line in a regulation. Keeping it out of ten thousand supply chains is a different job, and it’s the one that actually protects you.

Sources